Related to : Ranbaxy Laboratories Ltd Ranbaxy Laboratories Ltd BSE 14 May 13 | 12:00 AM 455.50 15.95 (3.63%) NSE 14 May 13 | 12:00 AM 455.65 15.95 (3.63%) For Ranbaxy Laboratories, the worst might not be over yet. Now, the Street is seeking a ... Smart Investor, 3 days ago
India's drive towards compulsory licensing, increasing patent challenges and denial of patent protection to anti-cancer drug Glivec have not gone down well with multinational drug makers who are grumbling that India has become a difficult market for ...Smart Investor, 1 month ago
In a landmark verdict, the Supreme Court last week dismissed Novartis plea for patent protection for cancer drug Glivec, ruling that the drug was not an innovation but a new form of a known drug. The decision can have wide-ranging implications for ...Financial Chronicle, 1 month ago
on your WebpageAdd Widget >Get your members hooked!